This virtual webinar titled “Is Colchicine the Third Pillar of Secondary Prevention of ASCVD?” is now available on demand. The webinar focuses on the secondary prevention of ASCVD and the practical application of colchicine in the clinical setting.

Faculty

  • Shaun Goodman, MD, MSc, FRCPC, FACC, FAHA, FESC, FCCS
  • Jean-Claude Tardif, CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS

Learning Objectives:

  • Recognize residual cardiovascular risk for patients with ASCVD despite the use of standard therapy
  • Assess the role of inflammation in ASCVD and the evidence for colchicine in patients with ASCVD and ACS
  • Evaluate the practical application of colchicine in the management of ASCVD through a case-based scenario